Souhaitez-vous accéder aux communiqués récents ?

TORONTO, 11 mars 2026 (GLOBE NEWSWIRE) -- Le Conseil canadien sur la reddition de comptes (CCRC) a publié ses premiers rapports d’inspection de chaque cabinet, marquant ainsi une étape importante...

CPAB has published its first individual firm inspection reports, marking a significant milestone in the evolution of CPAB’s public disclosure practices.

PYRUKYND (mitapivat) approved for adults with thalassemia in the United Arab Emirates

RxLogic Affirms Commitment to Compliance and Transparency as PBM Regulatory Expectations Expand

Siren Biotechnology Receives FDA Fast Track Designation for SRN-101 for the Treatment of Recurrent High-Grade Glioma

Agios today announced that the U.S. FDA has approved AQVESME™ (mitapivat), an oral pyruvate kinase (PK) activator, for thalassemia

Agios today announced that the U.S. Food and Drug Administration (FDA) has not yet issued a regulatory decision on the sNDA for mitapivat in thalassemia

EBC Financial Group announces regulatory approval of its South African subsidiary, positioning the firm for future access to the country’s financial sector

Agios today announced that the CHMP has adopted a positive opinion for the new indication for PYRUKYND in adults for anemia associated with thalassemia

DT-101 is designed to allow effective modulation of the AMPA receptor without compromising safetyPhase 2 clinical trial initiation anticipated before the end of 2025Trial builds on positive Phase 1...